EichorEICHOR
Location: Porto Alegre Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Porto Alegre

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Hospital de Clinicas de Porto Alegre- Site Number : 0760002 · Sanofi · NCT06867094Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Phase 2 · Hospital de Clínicas de Porto Alegre · Population Health Research Institute · NCT04680442PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Hospital de Clinicas de Porto Alegre · Boehringer Ingelheim · NCT07355296A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Irmandade Da Santa Casa de Misericordia de Porto Alegre · Hoffmann-La Roche · NCT06793215Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Hospital de Clinicas de Porto Alegre · Amgen · NCT07037433A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Irmandade da Santa Casa de Misericordia de Porto Alegre ( Si · Merck Sharp & Dohme LLC · NCT07216703The Caffeine Therapy in the Fetal to Neonatal Transition
Phase 4 · Hospital de Clínicas de Porto Alegre · Hospital de Clinicas de Porto Alegre · NCT05454332Comparative Experimental Study Between Bupivacaine and Ropivacaine Regarding Efficacy in Third Molar Removal Surgery Und
EARLY_Phase 1 · Hospital de Clínicas de Porto Alegre · Henrique Tedesco · NCT07108465Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
Phase 3 · Hospital Moinhos de Vento · Hospital Moinhos de Vento · NCT05199662Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Hospital de Clinicas de Porto Alegre · Eli Lilly and Company · NCT06937086A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Si · Merck Sharp & Dohme LLC · NCT06077760Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait
NA · Irmandade Santa Casa de Misericordia de Porto Alegre · Hospital Alemão Oswaldo Cruz · NCT05000697EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Hospital de Clinicas de Porto Alegre · Boehringer Ingelheim · NCT06531824A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Hospital de Clínicas de Porto Alegre · Daiichi Sankyo · NCT06330064A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Hospital de Clinicas de Porto Alegre · Biogen · NCT06962800A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Hospital de Clinicas de Porto Alegre · Boehringer Ingelheim · NCT07220083Cell Therapy Associated With Endobronchial Valve
Phase 2/Phase 3 · Hospital de Clinicas de Porto Alegre · Hospital de Clinicas de Porto Alegre · NCT04018729A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Associacao Hospitalar Moinhos de Vento · Janssen Research & Development, LLC · NCT06319820Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Hospital de Clínicas de Porto Alegre · Daiichi Sankyo · NCT06731478A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Porto Alegre Clinical Hospital (HCPA) · Takeda · NCT06499285Pan Tumor Rollover Study
Phase 2 · Local Institution - 0093 · Bristol-Myers Squibb · NCT03899155A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pi
Phase 2 · Hospital de Clinicas de Porto Alegre · Azafaros B.V. · NCT07399704A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-21019, Porto Alegre, Rio Grande do Sul · Colorado Prevention Center · NCT06033950Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Santa Casa de Misericordia de Porto Alegre · Protara Therapeutics · NCT05951179A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Hospital de Clinicas de Porto Alegre (HCPA) · Ipsen · NCT06016842A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Hospital de Clinicas de Porto Alegre · Bristol-Myers Squibb · NCT06561386A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
Phase 1/Phase 2 · Hospital de Clinicas de Porto Alegre (HCPA) · Prevail Therapeutics · NCT05487599Genomics and Microbiome Investigation in Cases of Recurrent Pregnancy Losses
Phase N/A · Hospital de Clínicas de Porto Alegre (HCPA) · Hospital de Clinicas de Porto Alegre · NCT06604338A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · Irmandade da Santa Casa de Misericórdia de Porto Alegre · Novo Nordisk A/S · NCT06717698A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niem
Phase 3 · Hospital de Clinicas de Porto Alegre (HCPA) - PPDS · Azafaros B.V. · NCT07082725
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.